You are here Home Vaccines Vaccines Vivotif Oral Details for Vivotif Oral vaccine and its components. Listen Print Share Twitter Facebook Email Recently added This page was added on 04 June 2018. Updates made This page was updated on [date-counter-updated-date]. View history of updates Sponsor Seqirus Administration route Oral Vaccine group Monovalent vaccines Description: Registered for use in people aged ≥6 years. Monovalent oral live attenuated typhoid vaccine 3 capsules in a blister pack. Each enteric-coated capsule contains: ≥2 x 109 viable organisms of live attenuated Salmonella typhi strain Ty21a bovine-derived gelatin ethylene glycol sucrose For Product Information and Consumer Medicine Information about Vivotif Oral visit the Therapeutic Goods Administration website. Additional vaccine information For detailed advice on vaccine dosage, administration, contraindications and precautions, and variations from product information, please visit the relevant disease chapter/s. Related diseases Typhoid fever Page history Last updated 4 June 2018 Last reviewed 4 June 2018 Is there anything wrong with this page? Help us improve the Australian Immunisation Handbook What you were doing? (required) What went wrong? (required) Leave this field blank
